PM-73G |
Influence on protein activity in presence of IFNγ |
Western Blot |
0.05 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT1 |
|
PM-73G |
Influence on protein activity in presence of IFNγ |
Western Blot |
0.10 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT1 |
|
PM-73G |
Influence on protein activity in presence of IFNγ |
Western Blot |
0.50 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT1 |
|
PM-73G |
Influence on protein activity in presence of IFNγ |
Western Blot |
1.00 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT1 |
|
PM-73G |
Influence on protein activity in presence of IFNγ |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT1 |
|
PM-73G |
Influence on protein activity in presence of EGF |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
p-STAT5 |
|
PM-73G |
Influence on protein activity in presence of EGF |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT5 |
|
PM-73G |
Influence on protein activity in presence of EGF |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity in presence of EGF |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on cell viability |
MTT |
50.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
5.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
|
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
p-STAT5 |
|
PM-73G |
Influence on protein activity |
Western Blot |
25.00 µM |
MDA-MB-468 |
Homo sapiens |
|
STAT5 |
|
PP2 |
Influence on protein activity |
Western Blot |
3.00 nM |
HEK293 |
Homo sapiens |
|
p-STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
10.00 nM |
HEK293 |
Homo sapiens |
|
p-STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
30.00 nM |
HEK293 |
Homo sapiens |
|
p-STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
3.00 nM |
HEK293 |
Homo sapiens |
|
STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
10.00 nM |
HEK293 |
Homo sapiens |
|
STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
30.00 nM |
HEK293 |
Homo sapiens |
|
STAT3 |
|
PP2 |
Influence on protein activity |
Western Blot |
3.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on protein activity |
Western Blot |
10.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on protein activity |
Western Blot |
30.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on protein activity |
Western Blot |
3.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on protein activity |
Western Blot |
10.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on protein activity |
Western Blot |
30.00 nM |
HEK293 |
Homo sapiens |
|
|
|
PP2 |
Influence on cell growth |
MTT |
4.00 nM |
T‑47D |
Homo sapiens |
|
|
|
PP2 |
Influence on cell growth |
MTT |
13.00 nM |
T‑47D |
Homo sapiens |
|
|
|
PP2 |
Influence on cell growth |
MTT |
39.00 nM |
T‑47D |
Homo sapiens |
|
|
|
Pravastatin |
Influence on atherosclerotic plaques development |
Hematoxilin and eosin stainig |
80.00 mg/kg |
vessel |
Mus musculus |
ApoE-/- |
|
|
Pravastatin |
Influence on atherosclerosis progression |
LDL level assesment |
80.00 mg/kg |
serum |
Mus musculus |
ApoE-/- |
|
|
Pravastatin |
Influence on atherosclerosis progression |
TC levels assesment |
80.00 mg/kg |
serum |
Mus musculus |
ApoE-/- |
|
|
Pravastatin |
Influence on atherosclerosis progression |
Hematoxilin and eosin stainig |
80.00 mg/kg |
vessel |
Mus musculus |
C57BL/6J |
|
|
Pravastatin |
Influence on atherosclerosis progression |
LDL level assesment |
80.00 mg/kg |
serum |
Mus musculus |
C57BL/6J |
|
|
Pravastatin |
Influence on atherosclerosis progression |
TC levels assesment |
80.00 mg/kg |
serum |
Mus musculus |
C57BL/6J |
|
|
Pravastatin |
Influence on atherosclerosis progression |
ELISA |
80.00 mg/kg |
serum |
Mus musculus |
ApoE-/- |
|
|
Pravastatin |
Influence on atherosclerosis progression |
ELISA |
80.00 mg/kg |
serum |
Mus musculus |
C57BL/6J |
|
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
ApoE-/- |
p-STAT3 |
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
C57BL/6J |
p-STAT3 |
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
ApoE-/- |
STAT3 |
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
C57BL/6J |
STAT3 |
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
ApoE-/- |
|
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
C57BL/6J |
|
|
Pravastatin |
Influence on atherosclerosis progression |
Western Blot |
80.00 mg/kg |
thoracoabdominal aortas |
Mus musculus |
ApoE-/- |
|
|